Clinical Trial Update: 3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women [NA]

View source ↗

Summary

A clinical trial evaluating 3.0 Tesla MRI for breast cancer detection in high-risk women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer, BRCA1 Mutation | NA | Status: WITHDRAWN